TGA Approval

ALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe (209223)

ARTG ID

209223

ARTG Name

ALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe

Sponsor

Sanofi-Aventis Australia Pty Ltd

ARTG Date

May 1, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

SANOFI-AVENTIS AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/c3731691b6fcf51d6d7d5c1967d62a00.pdf

https://medical-cdn.nocode.com/drug_tga/cc04ea083f37f592353a2f635230182c.pdf

Ingredient Name

eftrenonacog alfa

Empowering clinical research with data-driven insights and AI-powered tools.

ALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe (209223) - TGA 批准文号 | MedPath